Balyasny Asset Management LLC Karuna Therapeutics, Inc. Transaction History

Balyasny Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$161.01 - $317.85 $33.5 Million - $66.1 Million	208,093 Added 193.04%	315,892 $100 Million
Q3 2023 Nov 14, 2023	BUY	$164.66 - $218.08 $17.8 Million - $23.5 Million	107,799 New	107,799 $18.2 Million
Q1 2023 May 15, 2023	SELL	$161.33 - $204.36 $3.93 Million - $4.98 Million	-24,384 Reduced 76.84%	7,350 $1.34 Million
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $6.08 Million - $7.52 Million	31,734 New	31,734 $6.24 Million
Q2 2022 Aug 15, 2022	BUY	$93.97 - $143.33 $6.84 Million - $10.4 Million	72,802 New	72,802 $9.21 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.